Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers

References

• Hanahan D, Weinberg R A. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Reed J C. Mechanisms of apoptosis. Am J Pathol 2000; 157: 1415–1430
   PubMed Web of Science ®Google Scholar
• Wolter K G, Hsu Y T, Smith C L, Nechushtan A, Xi X G, Youle R J. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139: 1281–1292
   PubMed Web of Science ®Google Scholar
• Wei M C, Zong W X, Cheng E H, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727–730
   PubMed Web of Science ®Google Scholar
• Nechushtan A, Smith C L, Hsu Y T, Youle R J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 1999; 18: 2330–2341
   PubMed Web of Science ®Google Scholar
• Cuddeback S M, Yamaguchi H, Komatsu K, et al. Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 2001; 276: 20559–20565
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Karbowski M, Yamaguchi H, et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol 2005; 25: 9369–9382
   PubMed Web of Science ®Google Scholar
• Lee J W, Soung Y H, Kim S Y, et al. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006; 38: 312–315
   PubMed Web of Science ®Google Scholar
• Yang B, Gu F, Wang X. Expression of the bcl-2 and bax oncoprotein in TCC and its clinical significances. Zhonghua Wai Ke Za Zhi 1997; 35: 602–604
   PubMedGoogle Scholar
• Turunen N, Paakko P, Soini Y. Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax. Histol Histopathol 2000; 15: 53–60
   PubMed Web of Science ®Google Scholar
• Sauter G, Algaba F, Amin M, . Non-invasive urothelial neoplasias. WHO classification of non invasive papillary urothelial tumors. World Health Organisation Classification of Tumors, J N Eble, G Sauter, J I Epstein, I Sesterhenn, et al. IARC Press, Lyon 2004; 90–150, Pathology and Genetics: Tumors of the Urinary System and Male Genital Organs
   Google Scholar
• Yoo N J, Lee J W, Kim Y J, et al. Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS 2004; 112: 330–335
   PubMed Web of Science ®Google Scholar
• Palmerini F, Devilard E, Jarry A, Birg F, Xerri L. Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol 2001; 32: 461–467
   PubMed Web of Science ®Google Scholar
• Sturm I, Stephan C, Gillissen B, et al. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 2006; 13: 619–627
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Okada Y, Yoshida O, Fukumoto M, Bonavida B. Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity. Cancer 1997; 79: 1180–1189
   PubMed Web of Science ®Google Scholar
• Habara K, Ajiki T, Kamigaki T, Nakamura T, Kuroda Y. High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro. Jpn J Cancer Res 2001; 92: 1127–1132
   PubMedGoogle Scholar
• Lee S H, Shin M S, Park W S, et al. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res 1999; 59: 3068–3072
   PubMed Web of Science ®Google Scholar
• Shariat S F, Ashfaq R, Karakiewicz P I, Saeedi O, Sagalowsky A I, Lotan Y. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 2007; 109: 1106–1113
   PubMed Web of Science ®Google Scholar
• Bilim V N, Tomita Y, Kawasaki T, Takeda M, Takahashi K. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Lett 1998; 128: 87–92
   PubMed Web of Science ®Google Scholar
• Bilim V, Kasahara T, Hara N, Takahashi K, Tomita Y. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer 2003; 103: 29–37
   PubMed Web of Science ®Google Scholar
• Mikami T, Yanagisawa N, Baba H, Koike M, Okayasu I. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. Cancer 1999; 85: 318–325
   PubMed Web of Science ®Google Scholar